SG Americas Securities LLC Acquires New Holdings in AVANOS MEDICAL, INC. (NYSE:AVNS)

SG Americas Securities LLC purchased a new position in shares of AVANOS MEDICAL, INC. (NYSE:AVNS - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm purchased 24,031 shares of the company's stock, valued at approximately $344,000. SG Americas Securities LLC owned approximately 0.05% of AVANOS MEDICAL at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Illinois Municipal Retirement Fund raised its stake in shares of AVANOS MEDICAL by 3.1% during the 4th quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company's stock worth $402,000 after purchasing an additional 748 shares in the last quarter. Comerica Bank raised its stake in shares of AVANOS MEDICAL by 3.4% during the 4th quarter. Comerica Bank now owns 22,903 shares of the company's stock worth $365,000 after purchasing an additional 755 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of AVANOS MEDICAL by 3.6% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company's stock worth $411,000 after purchasing an additional 901 shares in the last quarter. EP Wealth Advisors LLC raised its stake in shares of AVANOS MEDICAL by 14.6% during the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company's stock worth $161,000 after purchasing an additional 1,289 shares in the last quarter. Finally, Gotham Asset Management LLC raised its stake in shares of AVANOS MEDICAL by 5.3% during the 4th quarter. Gotham Asset Management LLC now owns 28,234 shares of the company's stock worth $449,000 after purchasing an additional 1,425 shares in the last quarter. 95.17% of the stock is owned by hedge funds and other institutional investors.

AVANOS MEDICAL Stock Up 0.3%

Shares of AVNS traded up $0.04 during midday trading on Friday, reaching $12.21. 549,254 shares of the stock were exchanged, compared to its average volume of 380,656. The firm has a 50 day simple moving average of $12.46 and a 200-day simple moving average of $14.29. The company has a quick ratio of 1.56, a current ratio of 2.57 and a debt-to-equity ratio of 0.12. AVANOS MEDICAL, INC. has a 12-month low of $11.75 and a 12-month high of $25.36. The company has a market cap of $564.36 million, a price-to-earnings ratio of -1.46 and a beta of 1.14.

AVANOS MEDICAL (NYSE:AVNS - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.07. AVANOS MEDICAL had a positive return on equity of 6.26% and a negative net margin of 55.80%. The business had revenue of $167.50 million for the quarter, compared to the consensus estimate of $161.75 million. During the same period last year, the business earned $0.22 EPS. The firm's revenue was up .8% compared to the same quarter last year. Research analysts forecast that AVANOS MEDICAL, INC. will post 1.32 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised AVANOS MEDICAL from a "hold" rating to a "buy" rating in a research note on Wednesday, March 19th.

AVANOS MEDICAL Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.